BioCentury
ARTICLE | Clinical News

ALT-711: Phase IIb

September 23, 2002 7:00 AM UTC

ALT said it has enrolled 355 of a planned 450 patients with systolic hypertension without left ventricular hypertrophy in its U.S. Phase IIb SAPPHIRE trial. ...